Answers are grounded in this paper and cite their sources.
Background/Objectives: Kidney and ureteral stones (KUSs) are common recurrent urological disorders influenced by genetic, metabolic, inflammatory, and environmental factors. Although genome-wide association studies (GWASs) have identified susceptibility loci for nephrolithiasis, the effector genes and regulatory mechanisms underlying KUSs remain incompletely defined. Methods: We performed an integrative cross-tissue transcriptome-wide association study (TWAS) using FinnGen R12 GWAS summary statistics for KUSs (12,999 cases and 486,185 controls) together with Genotype-Tissue Expression (GTEx) v8 eQTL reference panels across 49 tissues. Candidate genes were prioritized using sparse canonical correlation analysis (sCCA), functional summary-based imputation (FUSION), multi-marker analysis of genomic annotation (MAGMA), summary-data-based Mendelian randomization (SMR), and fine-mapping of causal gene sets (FOCUS). Conditional and joint analysis, two-sample MR, network analysis, and druggability annotation were used for refinement and interpretation. Results: Cross-tissue and tissue-specific analyses identified 244 and 723 significant genes, respectively, with 172 overlapping genes and 156 refined TWAS candidates. Integration of five analytical layers yielded 20 high-confidence candidate genes, of which 11 showed significant associations between genetically predicted expression and KUS risk in cis-eQTL-based MR analyses: GCAT, GNL3, HLA-C, MXD3, NEK4, EIF4G3, EPRS1, HIBADH, MUL1, HYAL1, and USP40. Network analyses implicated metabolic regulation, immune response, protein translation, mitochondrial homeostasis, ubiquitin-mediated signaling, and extracellular matrix remodeling. Druggability assessment identified clinical development evidence for EPRS1, experimental pharmacological evidence for NEK4 and HYAL1, and predicted tractability for HLA-C. Conclusions: This integrative cross-tissue TWAS prioritized 11 candidate susceptibility genes for kidney and ureteral stones with MR evidence. These findings provide a genetic and transcriptomic basis for future functional validation and therapeutic exploration.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: